We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+1.34%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$73.5B
AUM Growth
+$844M
Cap. Flow
+$224M
Cap. Flow %
0.31%
Top 10 Hldgs %
9.54%
Holding
3,998
New
451
Increased
1,293
Reduced
1,502
Closed
554

Top Buys

Rank Stock Value
1
LOW icon
Lowe's Companies
LOW
+$638M
2
NVDA icon
NVIDIA
NVDA
+$461M
3
EQT icon
EQT Corp
EQT
+$400M
4
C icon
Citigroup
C
+$369M
5
CELG
Celgene Corp
CELG
+$339M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$694M
2
DELL icon
Dell
DELL
+$486M
3
IBM icon
IBM
IBM
+$341M
4
AMGN icon
Amgen
AMGN
+$306M
5
JNJ icon
Johnson & Johnson
JNJ
+$264M

Sector Composition

Rank Sector Weight
1 Technology 15.05%
2 Healthcare 10.49%
3 Consumer Discretionary 10.21%
4 Financials 8.38%
5 Industrials 7.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KGC icon
3326
Kinross Gold
KGC
$28.5B
$130K ﹤0.01%
+33,049
New +$132K
KG
3327
Kestrel Group
KG
$71.3M
$130K ﹤0.01%
+998
New +$139K
RIG icon
3328
CALL
Transocean
RIG
$5.92B
$129K ﹤0.01%
13,000
-109,700
-89% -$1.13M
ASXC
3329
DELISTED
Asensus Surgical, Inc.
ASXC
$128K ﹤0.01%
5,796
+936
+19% +$21.4K
ICL icon
3330
ICL Group
ICL
$6.81B
$124K ﹤0.01%
29,134
+7,800
+37% +$33.4K
PKD
3331
DELISTED
Parker Drilling Company
PKD
$124K ﹤0.01%
13,052
-8,688
-40% -$132K
JAX
3332
DELISTED
J. Alexander's Holdings, Inc.
JAX
$123K ﹤0.01%
10,742
-104,116
-91% -$1.05M
LPG icon
3333
Dorian LPG
LPG
$1.94B
$122K ﹤0.01%
16,226
-14,974
-48% -$115K
QTRH
3334
DELISTED
Quarterhill Inc. Common Shares
QTRH
$117K ﹤0.01%
81,000
-26,000
-24% -$43.8K
GNC
3335
CALL
DELISTED
GNC Holdings, Inc.
GNC
$116K ﹤0.01%
30,000
AREX
3336
DELISTED
Approach Resources Inc.
AREX
$115K ﹤0.01%
44,100
-28,020
-39% -$86.4K
KIN
3337
DELISTED
Kindred Biosciences, Inc.
KIN
$114K ﹤0.01%
13,163
-5,970
-31% -$52.4K
FLNA
3338
Filana Therapeutics
FLNA
$43M
$111K ﹤0.01%
15,657
-2,300
-13% -$15.5K
CLPR
3339
Clipper Realty
CLPR
$46.5M
$107K ﹤0.01%
12,657
-16,793
-57% -$152K
VOXX
3340
DELISTED
VOXX International Corporation Class A
VOXX
$105K ﹤0.01%
21,196
-9,295
-30% -$53.1K
NVLN
3341
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$103K ﹤0.01%
29,417
-10,790
-27% -$45.7K
NM
3342
DELISTED
Navios Maritime Holdings Inc.
NM
$101K ﹤0.01%
+11,254
New +$139K
IMUX icon
3343
Immunic
IMUX
$182M
$100K ﹤0.01%
37
-89
-71% -$204K
TPST icon
3344
Tempest Therapeutics
TPST
$14.8M
$100K ﹤0.01%
42
-41
-49% -$123K
NETS
3345
DELISTED
Netshoes (Cayman) Limited
NETS
$99K ﹤0.01%
16,785
+3,754
+29% +$30.3K
ORC
3346
Orchid Island Capital
ORC
$1.31B
$95K ﹤0.01%
2,579
-71,398
-97% -$2.75M
CBK
3347
DELISTED
Christopher & Banks Corporation
CBK
$93K ﹤0.01%
87,177
SGY.WS
3348
DELISTED
Stone Energy Corporation Warrants to purchase common stock (expiring February 28, 2021)
SGY.WS
$93K ﹤0.01%
12,800
OPK icon
3349
Opko Health
OPK
$921M
$92K ﹤0.01%
29,071
-35,719
-55% -$144K
GSUM
3350
DELISTED
Gridsum Holding Inc.
GSUM
$92K ﹤0.01%
+11,293
New +$120K

Similar funds

D.E. Shaw & Co's Q1 2018 Portfolio in Review

As of Q1 2018, D.E. Shaw & Co held 3,998 positions worth $73.5B, up 1.2% from $72.6B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

D.E. Shaw & Co's Q1 2018 filing shows 451 new, 1,293 increased, 1,502 reduced and 554 closed positions. Its largest new stake was GCI Liberty, Inc. Class A Common Stock (DE): 2,434,094 shares worth $129M. The largest sale was Meta Platforms (Facebook), an estimated $694M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • D.E. Shaw & Co's largest Q1 2018 buy was GCI Liberty, Inc. Class A Common Stock (DE): 2,434,094 shares worth $129M.
  • D.E. Shaw & Co added most to Lowe's Companies in Q1 2018, an estimated $638M increase.
  • D.E. Shaw & Co's biggest Q1 2018 reduction was Meta Platforms (Facebook), cutting an estimated $694M.
  • D.E. Shaw & Co fully exited Liberty Interactive Corporation Series A Liberty Ventures in Q1 2018, selling an estimated $141M.
  • D.E. Shaw & Co's ten largest holdings make up 9.5% of its $73.5B portfolio in Q1 2018.
  • D.E. Shaw & Co opened 451 new positions and closed 554 in Q1 2018.
  • D.E. Shaw & Co's portfolio value rose 1.2% quarter-over-quarter to $73.5B.

Based on D.E. Shaw & Co's 13F filing for Q1 2018, filed 15 May 2018.